A 43-year-old male patient presented with symmetrical and global weakness of the four limbs of progressive intensity, unable to walk, and altered sensitivity of the four limbs at a distal level.
Ten days before she had had a self-limiting episode of diarrhea, followed by symptoms of upper respiratory tract infection.
Neurological examination revealed weakness of the four limbs with muscle balance 3/5 proximally, 4/5 distally and universal areflexia.
Chest X-ray showed alterations suggestive of‚ñÅincipient pneumonia caused by COVID-19.
A positive result was obtained in the PCRof L SARS-CoV-2.
In the EMG conductive study, there was an increase in motor distal latencies and a decrease in the speeds of authentication of the nerves explored, as well as an increase in the minimum latency of the clinical wave SGB.
During admission, the pulmonology and neurology departments jointly assess the patient.
Intravenous immunoglobulin is administered for 5 days and the treatment indicated according to the protocol for patients COVID-19 with hydroxychloroquine sulfate, antiretrovirals (lopinavir and ritonavir), antibiotics (amoxicillin), corticosteroids and
During the first 2 days of hospitalization, the patient presented worsening of motor function, associating bilateral facial paresis and dysphagia.
Subsequently, the clinical evolution is satisfactory from both the neurological and respiratory point of view.
